- Also known as
- MT-II · MT2 · Melanotan 2 · MT-2
- Class
- Non-selective melanocortin receptor agonist (cyclic alpha-MSH analogue)
- Form
- Lyophilised powder, 10 mg vials, plus a ready-mixed nasal spray
- Sizes
- 10 mg
- Storage, dry
- −20 °C, dry and dark
- Storage, mixed
- 2–8 °C, use within 28 days of mixing (as generally reported for reconstituted peptides)
- BAC water per size
- 10 mg: 2 mL
- Molecular weight
- 1024.2 g/mol
What is Melanotan II?
In the literature Melanotan II is categorised as a non-selective melanocortin receptor agonist (cyclic alpha-MSH analogue), with a molecular weight of 1024.2 g/mol. Its recorded sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, in which a lactam bridge links Asp and Lys. Research published on it covers rat, mouse, human and zebrafish. It has been given to people in 3 studies, none controlled, so those findings cannot tease the compound apart from everything else that shifted at the same time. We keep it as lyophilised powder in 10 mg vials and a ready-mixed nasal spray; it is research material and nothing more. None of it is a medicine, and it is not for human or veterinary use.
What the research shows
| Study | Model | Dose used | Duration | Finding |
|---|---|---|---|---|
| Dreyer BA et al.2019 · BMJ Case Rep · PMID 30796078 | Human, single case report | Not stated in the abstract (abdominal subcutaneous injection) | Single presentation; 4-week follow-up | A man presented with low-flow priapism after injecting melanotan. It was managed without surgical shunting, but erectile function had not recovered at 4 weeks. |
| Peters B et al.2020 · CEN Case Rep · PMID 31953620 | Human, case report with literature review | Not stated in the abstract | Not stated in the abstract | The authors report a renal infarction most likely attributed to Melanotan II and note earlier reports of rhabdomyolysis and renal failure. They suggest a thrombotic effect and possible direct kidney toxicity as mechanisms. |
| Gilhooley E et al.2021 · Dermatology · PMID 34464955 | Human, qualitative study of online forums (623 entries, 205 participants, UK and Ireland) | Not stated in the abstract | Forum data from January 2016 to October 2017 | Users sought a tan before holidays and fitness or bodybuilding competitions. The authors flagged risks to pigmented skin lesions, infection, contaminated products, polypharmacy and sunbed use. |
| Wessells H et al.2003 · Ann N Y Acad Sci · PMID 12851302 | Rat (awake males; anaesthetised rats for intracorporal pressure) | Graded doses i.c.v., intrathecal and i.v.; optimal erectile response at 1 microgram i.c.v. and intrathecal | Single dose, erections scored for 90 min | MT-II produced dose-dependent penile erections through brain and lumbosacral spinal melanocortin receptors, blocked by SHU-9119. Injected directly into the penis it did not raise intracorporal pressure, so the action is central, not in the penis. |
| Strader AD et al.2007 · J Pharmacol Exp Ther · PMID 17567964 | Mouse (diet-induced obese and low-fat fed), replicated in diet-induced obese rats | Not stated in the abstract (peripheral administration) | Not stated in the abstract | Obese mice given MT-II lost weight and body fat, with reductions in both visceral and subcutaneous fat; low-fat fed mice kept their body weight. Pair-fed controls lost similar weight but kept more fat. |
| Seeley RJ et al.2005 · Endocrinology · PMID 15932932 | Rat, diet-induced obesity (some pre-restricted to different body weights) | Various doses by osmotic minipump (values not stated in the abstract) | 28 days | Whatever the starting body fat, final body fat was set by the MT-II dose, and MT-II rats had less body fat than vehicle rats. Food-restricted rats given MT-II ate more than ad libitum rats given MT-II. |
| Wekwejt P et al.2023 · Biomed Pharmacother · PMID 37478579 | Zebrafish, short-term high-fat diet | Not stated in the abstract | About three weeks of high-fat diet | A high-fat diet impaired recognition memory, raised anxiety-like behaviour and reduced exploration. Fish on the high-fat diet given MT-II behaved like the control-diet group. |
| Bednarek MA et al.1999 · Peptides · PMID 10447101 | Cell/receptor assays (human MC3, MC4 and MC5 receptors) and NMR | Not applicable (in-vitro binding and activation) | Not applicable | Swapping His for Ala left potency similar to MT-II, Arg to Ala cut potency about 100-fold, and Phe or Trp to Ala gave inactive compounds. Retro, enantio and retro-enantio analogues lost much of their potency. |
What these studies don't show: What human work there is remains uncontrolled: pilot studies, case reports and retrospective reviews. Without a control arm there is no way to pin the change on the compound. Neither the length of follow-up nor the number of participants will carry a safety conclusion. A certificate of analysis settles what the material is, not what it does.
Every study links to its PubMed record. See all Melanotan II studies in the research library →
Melanotan II price in Canada: 10mg vial
Buy Melanotan II in Canada in a 10mg vial, plus a nasal spray and a starter kit. Prices are in Canadian dollars, you pay by Interac e-Transfer or bank transfer, and orders are shipped from Canadian stock.
| Size | Price | Per mg |
|---|---|---|
| 10 mg | $43.00 | $4.30/mg |
Other formats and kits
Is Melanotan II available in Canada?
In Canada no Melanotan II product carries a Drug Identification Number, which means Health Canada has never assessed it for safety, efficacy or quality. We supply it solely as laboratory research material, with no use in a person or an animal intended. How Health Canada treats research peptides →
Side effects reported in studies
A small study finding no effect is not proof of safety. Every statement is bound to the study that reported it. None of the cited abstracts records a tolerability finding for Melanotan II. Read more →
Doses used in studies
Melanotan II FAQ
What is Melanotan II?
Melanotan II is classed as a non-selective melanocortin receptor agonist (cyclic alpha-MSH analogue), and that classification is where the published work begins. Research on it spans rat, mouse, human and zebrafish. Borealis Peptides keeps it as lyophilised powder in 10 mg vials and a ready-mixed nasal spray for in-vitro laboratory research. It holds no medicinal authorization and is not for use in any living subject. Each cited paper below is shown with the system it ran in and what it found.
Where can I buy Melanotan II in Canada?
It is dispatched within Canada from the stock we hold, in 10 mg vials. Nothing goes out until HPLC has confirmed identity and purity for that batch. Borealis Peptides takes research orders only and ships to research and business addresses. Because testing runs batch by batch, the certificate matches the vial rather than the product line.
Is Melanotan II legal in Canada?
In Canada no Melanotan II product carries a Drug Identification Number, which means Health Canada has never assessed it for safety, efficacy or quality. It is offered only as research material for lab work, never for use in a person or an animal. Because Health Canada has stated that "Research Use Only" labelling does not make a product legal to use in a person, we treat it as naming the terms of supply and not as leave to use the material.
How much Melanotan II should I use?
There is nothing to offer. Nothing on this site amounts to a protocol, a schedule or a reconstitution volume. The quantities in the cited studies belong to those studies and the models they were run in, and they appear here so the evidence can be judged instead of taken on trust.
What human evidence is there for Melanotan II?
Human work exists, but none of it is controlled. 3 studies involved people, in the form of pilots, case reports or retrospective reviews. Lacking a control group, these cannot show that the compound caused what was seen, and the page states as much beside the table.
How long does Melanotan II keep?
The sealed vial is stored at −20 °C, shielded from light and moisture. Solutions sit at 2–8 °C. The dry powder is unharmed by ambient transit and should be refrigerated once received. Light and repeated warming do more harm than the trip itself.
Does Melanotan II need bacteriostatic water?
The nasal spray comes as a finished solution in its own bottle, so nothing is added to it: no bacteriostatic water, no mixing, no transfer. The lyophilised vial is the only dry format supplied, and that is the single case where bacteriostatic water applies. It is sold separately.
How is the purity of Melanotan II confirmed?
Identity and purity are verified by HPLC for each batch, not once for the whole product. The certificate names the batch it covers, and that batch number is printed on the vial, so a result can be traced back to the exact material behind it. Quote your order number and we will send it.
How does Melanotan II compare with PT-141 and Melanotan I?
These are distinct compounds with distinct published records, and no ranking is offered here. PT-141 and Melanotan I carry 8 cited studies and 8 cited studies on their page against 8 here. The comparison worth making is to read both tables alongside the models each one used.
Why is Melanotan II named in a Health Canada advisory?
Because it was among the peptides seized from sellers offering unauthorized injectable products online. The advisory deals with material sold for people to inject without authorization. Borealis Peptides provides research material for the laboratory only and markets nothing for injection or for any use in a person, which is precisely the boundary the advisory sets.








